Is the high propensity of ethanolamine plasmalogens to form non-lamellar lipid structures manifested in the properties of biomembranes?
about
Mass spectrometric analysis reveals changes in phospholipid, neutral sphingolipid and sulfatide molecular species in progressive epilepsy with mental retardation, EPMR, brain: a case studyConnexin channels and phospholipids: association and modulationPhospholipid and sphingolipid metabolism in Leishmania.A Pex7 hypomorphic mouse model for plasmalogen deficiency affecting the lens and skeletonPlasmalogens: workhorse lipids of membranes in normal and injured neurons and glia.Dynamic, yet structured: The cell membrane three decades after the Singer-Nicolson modelEnhanced association of mutant triosephosphate isomerase to red cell membranes and to brain microtubulesAnalytical methods for (oxidized) plasmalogens: Methodological aspects and applications.Redirection of sphingolipid metabolism toward de novo synthesis of ethanolamine in Leishmania.Lipid remodelling in the reef-building honeycomb worm, Sabellaria alveolata, reflects acclimation and local adaptation to temperature.A Caenorhabditis elegans model for ether lipid biosynthesis and functionThermotropic and barotropic phase behavior of phosphatidylcholine bilayersPlasmenylethanolamine synthesis in Leishmania major.Plasmalogen enrichment in exosomes secreted by a nematode parasite versus those derived from its mouse host: implications for exosome stability and biology.Peroxisomes: a nexus for lipid metabolism and cellular signaling.Plasmalogens and fatty alcohols in rhizomelic chondrodysplasia punctata and Sjögren-Larsson syndrome.Coenzyme-A-Independent Transacylation System; Possible Involvement of Phospholipase A2 in Transacylation.Structural and functional roles of ether lipids.Lipid composition and the lateral pressure profile in bilayers.Mechanism of the lamellar/inverse hexagonal phase transition examined by high resolution x-ray diffraction.Deficiency in ethanolamine plasmalogen leads to altered cholesterol transport.Serum-free transfection of CHO-cells with tailor-made unilamellar vesicles.The biophysical properties of ethanolamine plasmalogens revealed by atomistic molecular dynamics simulations.Acetyl-l-carnitine as a possible therapy for Alzheimer's disease.Polyunsaturated chains in asymmetric lipids disorder raft mixtures and preferentially associate with α-Synuclein.Reduced muscle strength in ether lipid-deficient mice is accompanied by altered development and function of the neuromuscular junction.Peripheral ethanolamine plasmalogen deficiency: a logical causative factor in Alzheimer's disease and dementia.From peroxisomal disorders to common neurodegenerative diseases - the role of ether phospholipids in the nervous system.Neuronal Lipid Metabolism: Multiple Pathways Driving Functional Outcomes in Health and Disease.Alterations in the Plasma Levels of Specific Choline Phospholipids in Alzheimer's Disease Mimic Accelerated Aging.Substantial Decrease in Plasmalogen in the Heart Associated with Tafazzin Deficiency.Plasmalogen lipids: functional mechanism and their involvement in gastrointestinal cancer.
P2860
Q24313553-5F28B56C-476C-4D5B-A368-43AF9398A70FQ24645921-CFE0A7DF-E88B-4C1B-A17A-39F2ADF83901Q33625755-BBE795AB-9B5D-4C24-B7BA-BA0A0BCC1596Q33729632-80875A7B-5B9E-43F1-8D78-EF7FE17176C9Q33954014-74D40090-87D4-47C6-95E0-B47032218056Q34209789-F8BD9BF2-4CEA-4AA6-9325-4FDC03DDC872Q34999755-911D4B93-2A5C-4ADB-9E71-C503FA391AF9Q35533292-8F3209E1-B873-4C00-81E5-322AFAE32980Q35752867-D053671B-748B-4AB8-8075-3D3DC337D1D0Q36168725-93E4575B-357F-4569-952C-C58D3F064A2EQ36503836-6878FD4F-DF73-4288-A0A2-5586D457F9BFQ36655936-D92F8D4F-792F-47B1-8D2C-277568237CEDQ37072066-D07F99A7-C48B-4FDF-A414-3A4E78A94C4AQ37077489-D9207927-4970-4319-A4FA-797372D2CD92Q37633445-402E2265-762F-4E23-ADFA-2B8DABA9BD8EQ38272446-9C1922F7-13B6-4600-9AD7-3C561724416EQ39208689-5A62798F-1979-4039-86A1-4488365818EDQ39317295-10686A84-98BF-4F82-8F4C-256E1B1F0327Q40142623-18996413-B80D-44AA-9298-16F4C1C42448Q40235803-0BA46F6F-92FE-4ADD-B170-946E93D479B6Q40611683-4EBEBA2C-483A-4681-A107-7DD189B2E4C3Q43076244-6ADD2CF0-D627-43D7-907B-1721E5C1D20CQ43139084-78E380AD-8367-450B-AB7F-9D927B8349A8Q43265605-5748E95F-F8B0-4578-936B-E2BB24B81F05Q47133254-D8034EF9-2F72-47D2-BA1F-77199C69B38EQ47140716-FCA55DCB-B09F-446A-95B4-32EC9D265996Q48090023-01381062-09DA-4D92-BC5C-87705A4C40AAQ48159157-FBDE9E17-7BF9-4255-8785-27467C19E3E7Q49334640-9482EA27-EAC8-45A8-8D3C-BF20B025E0F6Q50417000-CCD4EC75-5843-4A5F-9931-C174D973C954Q51737988-224D76AB-C2A6-46CA-969D-DE2BCE0CFD65Q54942543-0A716609-6017-4A25-A9CD-848C1CB1C6ED
P2860
Is the high propensity of ethanolamine plasmalogens to form non-lamellar lipid structures manifested in the properties of biomembranes?
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Is the high propensity of etha ...... he properties of biomembranes?
@en
type
label
Is the high propensity of etha ...... he properties of biomembranes?
@en
prefLabel
Is the high propensity of etha ...... he properties of biomembranes?
@en
P1476
Is the high propensity of etha ...... he properties of biomembranes?
@en
P2093
P304
P356
10.1016/0009-3084(96)02580-7
P577
1996-07-01T00:00:00Z